Arthur S. Przybyl will depart as President and Chief Executive Officer of ANI Pharmaceuticals, Inc. on May 10, 2020. The Board of Directors has retained an executive search firm to search for a new president and chief executive officer.

Mr. Przybyl said, “After 11 years as President and CEO of ANI, the Board and I have determined that the time is right to transition to new leadership as the Company prepares to launch Cortrophin® Gel and expand its portfolio of specialty pharmaceutical products.  Since 2009, I have achieved my goals of transforming ANI’s business model and growing ANI into the profitable and sustainable business that it is today.  Perhaps most importantly, over the past four years we have taken the Cortrophin® Gel opportunity from concept to FDA filing, and with it, plan to introduce much needed competition to the market.  These achievements are a testament to our strong management team and talented employees that I am confident can successfully direct the Company going forward and I want to thank them for the transformative work we, as a team, have achieved.”

Robert E. Brown, Jr., Chairman of the Board of Directors of ANI, said, “On behalf of the entire Board, I would like to thank Art for his many contributions to ANI during his tenure at the Company.  Under his leadership, the Company has seen continued and strong growth and diversification of its commercial product offerings and portfolio of pipeline products. We wish him well in his future endeavors.”